Hospital-based survey of doctors' attitudes to adverse drug reactions and perception of drug-related risk for adverse reaction occurrence

Pharmacoepidemiology and Drug Safety

Volumn 8, Issue SUPPL. 1, 1999, Pages

  Cosentino, Marco ^a   Leoni, Olivia ^a   Oria, Cristina ^a   Michielotto, Donatella ^a   Massimo, Enrica ^a   Lecchini, Sergio ^a   Frigo, Gianmario ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

Adverse drug reaction reporting systems; Adverse drug reactions; Attitudes of health personnel; Hospital doctors; Questionnaires

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ANTILIPEMIC AGENT; DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; SPASMOLYTIC AGENT;

ADVERSE DRUG REACTION; CONFERENCE PAPER; DRUG SURVEILLANCE PROGRAM; HOSPITAL PATIENT; HOSPITAL PHYSICIAN; ITALY; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; RISK;

EID: 0032908716     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1557(199904)8:1+3.0.CO;2-Q     Document Type: Conference Paper

References (28)

1. Lumley, C. E., Walker, S. R., Hall, G. C., Staunton, N. and Grob, P. R. The under-reporting of adverse drug reactions seen in general practice. Pharmaceut. Med. 1986; 1: 205-212.
2. Pierfitte, C., Hanesse, B. and Royer, R. J. Enquête d'opinion sur la pharmacovigilance Européenne: le sentiment des médecins français. Thérapie 1995; 50: 171-172.
3. Moride, Y., Haramburu, F., Requejo, A. A. and Bégaud, B. Under-reporting of adverse drug reactions in general practice. Br. J. Clin. Pharmacol. 1997; 43: 177-181.
4. Bégaud, B., Tubert, P. and Haramburu, F. et al. Comparing toxicity of drugs: use and misuse of spontaneous reporting. Post Marketing Surveillance 1991; 5: 69-76.
5. Belton, K. J., Lewis, S. C., Payne, S. and Rawlins, M. D. Attitudinal survey of adverse drug reaction reporting by medical practitioners in the United Kingdom. Br. J. Clin. Pharmacol. 1995; 39: 223-226.
6. Bateman, D. N., Sanders, G. L. S. and Rawlins, M. D. Attitudes to adverse drug reaction reporting in the Northern Region. Br. J. Clin. Pharmacol. 1992; 34: 421-426.
7. Robins, A. H., Weir, M. and Biersteker, E. M. Attitudes to adverse drug reactions and their reporting among medical practitioners. S. Afr. Med. J. 1987; 72: 131-134.
8. Belton KJ, and The European Pharmacovigilance Research Group. Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. Eur. J. Clin. Pharmacol. 1997; 52: 423-427.
9. Bradley, C. P. Factors which influence the decision whether or not to prescribe: the dilemma facing general practitioners. Br. J. Gen. Pract. 1992; 42: 454-458.
10. Britten, N. and Ukoumunne, O. The influence of patients' hopes of receiving a prescription on doctors' perceptions and the decision to prescribe: a questionnaire survey. Br. Med. J. 1997; 315: 1506-1510.
11. Cockburn, J. and Pit, S. Prescribing behaviour in clinical practice: patients' expectations and doctors' perceptions of patients' expectations - a questionnaire study. Br. Med. J. 1997; 315: 520-523.
12. Lopez de Maturana, A., Morago, V., San Emeterio, E. and Gorostiza, J. Attitudes of general practitioners in Bizkaia, Spain, towards the terminally ill patient. Palliative Med. 1993; 7: 39-45.
13. Segal, R. and Hepler, C. D. Drug choice as a problem-solving process. Med. Care 1985; 23: 967-976.
14. Gardner, M. O., Bronstein, J., Goldenberg, R. L., Haywood, J. L., Cliver, S. P. and Nelson, K. G. Physician opinions of preterm infant outcome and their effect on antenatal corticosteroid use. J. Perinatol. 1996; 16: 431-434.
15. Einarson, T. R. Drug-related hospital admissions. Ann. Pharmacother. 1993; 27: 832-840.
16. Muhelberger, N., Schneeweiss, S. and Hasford, J. Adverse drug reaction monitoring - cost and benefit considerations Part I: frequency of adverse drug reactions causing hospital admissions. Pharmacoepidemiol. Drug Safety 1997; 6: S71-S77.
17. Steel, K., Gertman, P. M. and Crescenzi, C. Iatrogenic illness on a general medicine service at a university hospital. N. Engl. J. Med. 1981; 304: 638-642.
18. Jick, H., Madsen, S., Nudelman, P. M., Perera, D. R. and Stergachis, A. Postmarketing follow-up at group health cooperative of Puget Sound. Pharmacotherapy 1984; 4: 99-100.
19. Stoukides, C. A., D'Agostino, P. R. and Kaufman, M. B. Adverse reaction surveillance in an emergency room. Am. J. Hosp. Pharm. 1993; 50: 712-714.
20. Classen, D. C., Pestotnik, S. L., Evans, R. S., Lloyd, J. F. and Burke, J. P. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1997; 277: 310-306.
21. Moore, N., Lecointre, D., Noblet, C. and Mabille, M. Frequency and cost of serious adverse drug reactions in a department of general medicine. Br. J. Clin. Pharmacol. 1998; 45: 301-308.
22. Lazarou, J., Pomeranz, B. H. and Corey, P. N. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279: 1216-1217.
23. Koch-Weser, J., Sidel, V. W., Sweet, R. H., Kanarek, P. and Eaton, A. E. Factors determining physician reporting of adverse drug reactions. N. Engl. J. Med. 1969; 280: 20-26.
24. Milstien, J. B., Faich, G. A., Hsu, J. P., Knapp, D. E., Baum, C. and Dreis, M. W. Factors affecting physician reporting of adverse drug reactions. Drug Inf. J. 1986; 20: 157-164.
25. Tallarida, R. J., Murray, R. B. and Elben, C. A scale for assessing the severity of diseases and adverse drug reactions. Application to drug benefit and risk. Clin. Pharmacol. Ther. 1979; 25: 381-390.
26. British National Formulary. No. 35, The Pharmaceutical Press, London, 141-145.
27. Vance, M. A. and Millington, W. R. Principles of irrational drug therapy. Int. J. Health Serv. 1986; 16: 355-362.
28. Joelson, S., Joelson, I.-B. and Wallander, M.-A. Geographical variation in adverse event reporting in clinical trials. Pharmacoepidemiol. Drug Safety 1997; 6: S31-S35.